Why should the radioiodine dose be different in patients with differentiated thyroid carcinoma prepared with recombinant human TSH?

Author: Pitoia Fabián   Degrossi Osvaldo   Niepomniszcze Hugo  

Publisher: Springer Publishing Company

ISSN: 1619-7070

Source: European Journal of Nuclear Medicine and Molecular Imaging, Vol.31, Iss.6, 2004-06, pp. : 924-924

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content